NORTH READING, Mass.--(BUSINESS WIRE)--
Inc. (NYSE:TER) announced the election of Marilyn Matz to its Board
of Directors effective July 3, 2017. Ms. Matz was also appointed to the
Board’s Compensation Committee and the Nominating and Corporate
Ms. Matz has more than 35 years of experience in automation, machine
vision and software analytics related technologies. After cofounding
Cognex, a leader in vision systems, Ms. Matz held a variety of
leadership positions in engineering and business operations at the
company. She is a cofounder and current CEO and board chair of
Paradigm4, a scientific analytics software company empowering data
scientists, bioinformatics researchers, and scientists to tackle data
management and complex analytics challenges with big and diverse data.
Ms. Matz earned degrees in computer science from Syracuse University and
“We are very pleased that Marilyn is joining our Board of Directors,”
said Roy Vallee, Teradyne Chairman. “Her technical expertise and
experience in the automation and vision fields will be especially
valuable to our Board as Teradyne continues to strengthen its position
in the global electronics and industrial automation industries.”
(NYSE:TER) is a leading supplier of automation equipment for test and
industrial applications. Teradyne Automatic Test Equipment (ATE) is used
to test semiconductors, wireless products, data storage and complex
electronic systems, which serve consumer, communications, industrial and
government customers. Our Industrial Automation products include
Collaborative Robots used by global manufacturing and light industrial
customers to improve quality and increase manufacturing efficiency. In
2016, Teradyne had revenue of $1.75 billion and currently employs
approximately 4,300 people worldwide. For more information, visit www.teradyne.com.
Teradyne(R) is a registered trademark of Teradyne, Inc. in
the U.S. and other countries.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170619005679/en/
Andy Blanchard, 978-370-2425
Source: Teradyne, Inc.